{
    "Trade/Device Name(s)": [
        "VALIDATE\u00ae Cardiac Marker Calibration Verification Test Sets",
        "VALIDATE\u00ae CM1 Calibration Verification Test Set"
    ],
    "Submitter Information": "Maine Standards Company",
    "510(k) Number": "K053247",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040277"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "November 10, 2005",
    "Summary Letter Received Date": "November 21, 2005",
    "Submission Date": "November 7, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "CK-MB",
        "Myoglobin"
    ],
    "Specimen Type(s)": [
        "Human Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Abbott AxSym instrument system"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibration Verification Test Set",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for VALIDATE Cardiac Marker Calibration Verification Test Sets for verifying calibration and linearity of CK-MB and Myoglobin in human serum on automated, semi-automated and manual chemistry systems.",
    "Indications for Use Summary": "Used by trained laboratory professionals for quantitatively verifying calibration, validating reportable ranges, and determining linearity in automated, semi-automated and manual chemistry systems for CK-MB and Myoglobin.",
    "fda_folder": "Clinical Chemistry"
}